We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Navamedic Asa | LSE:0FDB | London | Ordinary Share | NO0010205966 | NAVAMEDIC ORD SHS |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 12.10 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 382.14M | 29.43M | 1.7083 | 7.08 | 208.46M |
From May 2023 to May 2024
OSLO, Norway, May 31, 2023 /PRNewswire/ -- Following Navamedic ASA's acquisition of Sensidose AB, the nomination committee recommends that Åsa Kornfeld, previous Board member in Sensidose AB, is elected as a new Navamedic ASA Board member in addition to Terje Bakken (Chairman), Narve Reiten, Jostein Davidsen, Annika Kollén and Edmée Steenken on the Annual General Meeting on June 1st, 2023.
Åsa Kornfeld served as a Board member of Sensidose AB when Navamedic ASA acquired the company. She is Pricing & Access Lead in Recordati Rare Diseases based in Paris, and has extensive experience from the pharmaceutical industry, with more than 25 years of international experience. She holds an M.Sc Medicines and Healthcare products from Université de Bordeaux, and Finance for Executives from INSEAD.
On behalf of the nomination committee,
Bernt Olav Røttingsnes
For further information, please contact:
Kathrine G. Andreassen, CEO, Navamedic, Mobile: +47 951 78 680 E-mail: kathrine@navamedic.com
Lars Hjarrand, CFO, Navamedic, Mobile: +47 917 62 842 E-mail: lars.hjarrand@navamedic.com
View original content:https://www.prnewswire.co.uk/news-releases/updated-recommendation-by-the-nomination-committee-of-navamedic-asa-301838605.html
Copyright 2023 PR Newswire
1 Year Navamedic Asa Chart |
1 Month Navamedic Asa Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
